Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD1

.

Source: Expert Opinion on Therapeutic Targets - September 14, 2023 Category: Drugs & Pharmacology Authors: Wei JiangZhiwei YangPu ChenMan ZhaoYubo WangJingyuan WangXinru LiMeichen WangPeng Houa Key Laboratory for Tumor Precision Medicine of Shaanxi Province and Department of Endocrinology, The First Affiliated Hospital of Xi ’an Jiaotong University, Xi’an, Source Type: research